Abstract: A solid powder product with a Ca/P ratio of between 1.40 and 1.90 is prepared from tricalcium phosphate and tetracalcium phosphate. An aqueous solution containing calcium ions and phosphate ions with a Ca/P ratio higher than 0.20 and lower than 0.50 is prepared. The aqueous solution and the solid powder product and optionally water are mixed to obtain a mixture with a liquid/solid weight ratio of between 0.30 and 0.65 and a resulting paste with a Ca/P ratio of between 1.50 and 1.67.

Abstract: The invention is directed to a method for making a silicoaluminophosphate (SAPO) molecular sieve from a reaction mixture comprising components present in amounts sufficient to form the SAPO, the reaction mixture having a first pH. The method comprises the steps of: adding an acid to the reaction mixture after the reaction mixture undergoes a change in pH from the first pH; and crystallizing the SAPO from the reaction mixture. The present invention is also directed to a silicoaluminophosphate molecular sieve made by this process.

Abstract: A process to prepare an improved fluid rare earth phosphate catalyst composition useful in preparing alkylene oxide adducts of organic compounds having active hydrogen atoms is provided. The catalyst is prepared by dissolving a rare earth salt in a C9-C30 active hydrogen containing organic compound and then adding phosphoric acid to the organic compound rare earth mixture.

Abstract: A molecular sieve and a molecular sieve catalyst containing a surface heat impregnated with a metal. The molecular sieve is heated in the presence of a metal containing solution at a temperature between 30° C. and 400° C. then separated from the metal containing solution. The molecular sieve and molecular sieve catalyst is used to make olefin from an oxygenate feedstock.

Abstract: There is provided macrostructures of porous inorganic material which can have controlled size, shape, and/or porosity and a process for preparing the macrostructures. The macrostructures comprise a three-dimension network of particles of porous inorganic materials. The process for preparing the macrostructures involves forming an admixture containing a porous organic ion exchanger and a synthesis mixture capable of forming the porous inorganic material and then converting the synthesis mixture to the porous inorganic material. After formation of the composite material, the porous organic ion exchanger can be removed from the composite material to obtain the macrostructures.

Abstract: A calcium phosphate bone graft material comprising an amorphous calcium phosphate glassy phase of from about 30 to about 100 volume % is obtained by plasma spraying calcium phosphate-containing powder onto a target to produce a deposited layer and removing the deposited layer from the target to provide the calcium phosphate bone graft material.

Abstract: A composition providing thermal, corrosion, and oxidation protection at high temperatures is based on a synthetic aluminum phosphate, in which the molar content of aluminum is greater than phosphorous. The composition is annealed and is metastable at temperatures up to 1400° C.

Abstract: The present invention relates to a pharmaceutical composition comprising lisinopril and dibasic calcium phosphate dihydrate (DCPD), produced by a process comprising mixing lisinopril and DCPD with a specific surface area of less than 1.5 m2g−1. The use of large particle sized DCPD in a lisinopril formulation/composition has the effect of reducing the amount of the lisinopril degradation product DKP that is formed, thereby increasing the shelf-life of tablets formulated with the larger sized DCPD, particularly those with low doses of lisinopril.

Abstract: A novel intercalation compound is provided, in which compound monohydric alcohol is intercalated between layers of a layered compound comprising vanadium, phosphorus and oxygen as primary components, characterized in that the monohydric alcohol is aliphatic secondary monohydric alcohol, alicyclic monohydric alcohol, or aromatic monohydric alcohol By heating the intercalation compound, a vanadium-phosphorus mixed oxide having a BET specific surface area of at least 80 m2/g can be obtained.

Abstract: Shaped, composite bodies are provided. One portion of the shaped bodies comprises an RPR-derived porous inorganic material, preferably a calcium phosphate. Another portion of the composite bodies is a different solid material, preferably metal, glass, ceramic or polymeric. The shaped bodies are especially suitable for orthopaedic and other surgical use.

Abstract: A mesoporous aluminophosphate material includes a solid aluminophosphate composition modified with at least one element selected from zirconium, cerium, lanthanum, manganese, cobalt, zinc, and vanadium. This mesoporous aluminophosphate material has a specific surface area of at least 100 m2/g, an average pore size less than or equal to 100 Å, and a pore size distribution such that at least 50% of the pores have a pore diameter less than 100 Å. The material can be used as a support for a catalytic cracking catalyst. Additionally, a method for making such a mesoporous aluminophosphate material is disclosed. The method, which preferably avoids use of organic reagents or solvents, includes providing an aqueous solution containing an inorganic phosphorus component; an inorganic aluminum containing component; and an inorganic modifying component containing at least one element selected from zirconium, cerium, lanthanum, manganese, cobalt, zinc, and vanadium.

Abstract: This invention relates to novel sol-gel calcium phosphate, in particular hydroxyapatite ceramic coatings and processes of making same at low temperature. Such coatings are useful, inter alia, for dental implants and bone-metal contact appliances. A sol-gel process for preparing a crystallized hydroxyapatite which comprises: (a) hydrolysing a phosphor precursor in a water based medium; (b) adding a calcium salt precursor to the medium after the phosphite has been hydrolysed to obtain a hydroxyapatite gel; and (c) calcining the crystallized hydroxyapatite at a suitable elevated temperature.

Abstract: A photocatalyst comprising a porous material, wherein said porous material comprises a compound with a basic framework having metal atoms bonded to phosphorus atoms by way of oxygen atoms, said metal atoms being selected from the group consisting of titanium atoms and zirconium atoms.

Abstract: A process for removing impurities contained in the crystal lattice of minerals, comprising the steps of forming a mixture of a mineral capable of structurally reorganizing its crystal lattice which contains an impurity in its crystal lattice and a halogen anion, and water; heating the mixture to the mineral's structural reorganization transition temperature; holding the mixture at the structural reorganization transition temperature for a sufficient period of time to allow the impurity to freely migrate from the lattice to combine with the halogen anion; and separating the combined impurity and anion from the mixture to render the mineral essentially free of the impurity. The process is applicable to numerous minerals and impurities, but is especially useful to remove arsenic from fluorspar. Numerous halogen anions can be employed, such as chlorides, fluorides, bromides and iodides, but the preferred halogen anion is a metal chloride such as calcium chloride.

Abstract: Uniformly sized and shaped particles of metal salts are provided comprised of one or more metal cations in combination with one or more simple oxoacid anions and a general method for the controlled precipitation of said metal salts from aqueous solutions. The methods proceed via the in situ homogeneous production of simple or complex oxoacid anions in which one or more of the nonmetallic elements e.g. Group 5B and 6B (chalcogenides), and 7B (halides) comprising the first oxoacid anion undergo oxidation to generate the precipitant anionic species along with concurrent reduction of the nonmetallic element of a second, dissimilar oxoacid anion. The oxoacid anions are initially present in solution with one or more metal cations known to form insoluble salts with the precipitant anion.

Abstract: This invention relates to the synthesis of large pore composite molecular sieves and to the synthetic large pore composite molecular sieves so produced. The molecular sieves of the invention have the same general utilities of the comparable molecular sieves of the prior art but have been found to be superior catalysts and absorbents. This invention relates to a hydrothermal synthesis of large pore molecular sieves from nutrients, at least one of which contains an amorphous framework-structure, and which framework-structure is essentially retained in the synthetic molecular sieve. This invention stems from a discovery that the intrinsic porosity characteristics of a nutrient that possesses an amorphous cation oxide-framework can be substantially retained in the final molecular sieve containing product formed by a hydrothermal process by carefully controlling the conditions under which the hydrothermal process is conducted.

Abstract: A biphasic cement of &agr;-TCP/HAP is primarily composed of 30-60 wt % &agr;-tricalcium phosphate (Ca3(PO4)2, &agr;-TCP) and 40-70 wt % of hydroxyapatite (Ca10(PO4)6(OH)2, HAP). The biphasic cement of &agr;-TCP/HAP of the present invention is superior since it can set rapidly while soaking in a water solution. The present invention also provides a process for preparing the biphasic cement of &agr;-TCP/HAP, in which the composition of the biphasic cement of &agr;-TCP/HAP can be controlled.

Abstract: Microporous crystalline silico-alumino-phosphate (SAPO) compositions, catalytic materials comprising the composition, and use of these for production of olefins from methanol. The catalysts contain silico-alumino-phosphate materials with AEI/CHA-mixed phase composition. The catalysts have prolonged life compared to those belonging to the prior art.

Abstract: Calcium phosphate compositions that are particularly useful and unique as orthopedic and dental cements and remineralizers, as well as methods and kits for their use, and the resulting products are disclosed. The compositions comprise tetracalcium phosphate which has been prepared from a mixture with a calcium to phosphorous ratio of less than 2, or prepared and maintained under substantially anhydrous conditions prior to use or, preferably, both. The novel compositions are converted substantially to hydroxyapatite upon setting, are substantially gradually resorbable and replaced by bone when implanted in contact with living bony tissue, and offer distinct advantages in terms of cement strength, setting time and reliability and other properties.

Abstract: Uniformly sized and shaped particles of metal salts are provided comprised of one or more metal cations in combination with one or more simple oxoacid anions and a general method for the controlled precipitation of said metal salts from aqueous solutions. The methods proceed via the in situ homogeneous production of simple or complex oxoacid anions in which one or more of the nonmetallic elements e.g. Group 5B and 6B (chalcogenides), and 7B (halides) comprising the first oxoacid anion undergo oxidation to generate the precipitant anionic species along with concurrent reduction of the nonmetallic element of a second, dissimilar oxoacid anion. The oxoacid anions are initially present in solution with one or more metal cations known to form insoluble salts with the precipitant anion.

Abstract: A method for the preparation of small zeotype crystals with controlled sizes comprising the steps of synthesizing inside a porous material having a majority of pores less than 1000 Å a synthesis gel consisting essentially of (a) a zeotype precursor composition comprising hydratized oxides of Si, Al and P and metal compounds (b) a zeolite template; and heating or autoclaving the porous support material containing synthesis gel, whereby zeotype crystals are formed; and rinsing and drying the porous support material containing zeotype crystals.

Abstract: A catalyst for converting methanol to light olefins along with the process itself are disclosed and claimed. The catalyst is a metalloaluminophosphate molecular sieve having the empirical formula (ELxAlyPz)O2 where EL is a metal such as silicon or magnesium and x, y and z are the mole fractions of EL, Al and P respectively. The molecular sieve has predominantly a plate crystal morphology in which the average smallest crystal dimension is at least 0.1 microns and has an aspect ratio of no greater than 5. Use of this catalyst gives a product with a larger amount of ethylene versus propylene.

Abstract: A process for the production of a synthetically produced bentonite-type inorganic microparticle. The synthetic microparticle produced according to the process of the present invention is particularly useful in papermaking processes where retention, water drainage, sheet formation and tangible cost saving opportunities are important.

Abstract: A new family of crystalline manganese phosphate compositions has been prepared. These compositions have an extended network which network can be a one-, two-, or three-dimensional network. The composition has an empirical formula of:(A.sup.3+).sub.v (Mn.sup.b+)(M.sup.c+).sub.x P.sub.y O.sub.zwhere A is a structure directing agent such as an alkali metal, M is a metal such as Al, Fe.sup.3+ and "b" is the average manganese oxidation state and varies from greater than 2.0 to a maximum of 3.0. These compositions can be used as adsorbents and as catalysts in the oxidation of hydrocarbons.

Abstract: A method is disclosed for the manufacture of a ceramic material for fillings or dental prostheses, which includes the steps of forming a precipitation product having at least one slightly soluble calcium phosphate compound, which has at least two phases of crystals; the slightly soluble calcium phosphate compound being a replacement for dental tissue. The precipitation product further includes a freely soluble compound dissolvable in the saliva of a patient's mouth and which creates a porous structure within the slightly soluble phase. The pores of this structure are filled by precipitating ions from the patient's saliva. The precipitation product is then sintered and dried, before being explosively compressed to form the ceramic dental filing material.

Abstract: A metal oxide is treated with an organophosphate, such as a trialkyl phosphate, to convert the oxide to the corresponding phosphate. The metal in the oxide can be a transition metal, such as iron, and the trialkyl phosphate preferably contains from one to about four carbon atoms in each alkyl group. The treatment can be conducted at an elevated temperature of about 250.degree. C. or greater.

Abstract: Microporous crystalline metallophosphate composition having an essential framework structure identified by the characteristic X-ray powder diffraction reflections given in Table I, and whose chemical composition in the calcined anhydrous form expressed in terms of mole ratios of oxides is: (M.sub.x Al.sub.y P.sub.z)O.sub.2 where M is silicon, x+y+z=1, and where x, y and z represent the mole fractions of silicon, aluminium and phosphorous present in the product, and where x may have a value from 0 to 0.5, y may have a value from 0.25 to 0.5 and z may have a value from 0.25 to 0.5. The invention also describes a method for preparing the products from a reaction mixture which includes both monovalent cations and fluoride.

Abstract: A process for removing impurities contained in the crystal lattice of minerals, comprising the steps of forming a mixture of a mineral capable of structurally reorganizing its crystal lattice which contains an impurity in its crystal lattice and a halogen anion, and water; heating the mixture to the mineral's structural reorganization transition temperature; holding the mixture at the structural reorganization transition temperature for a sufficient period of time to allow the impurity to freely migrate from the lattice to combine with the halogen anion; and separating the combined impurity and anion from the mixture to render the mineral essentially free of the impurity. The process is applicable to numerous minerals and impurities, but is especially useful to remove arsenic from fluorspar. Numerous halogen anions can be employed, such as chlorides, fluorides, bromides and iodides, but the preferred halogen anion is a metal chloride such as calcium chloride.

Abstract: This invention involves new compositions and methods of use and delivery of amorphous calcium compounds such as: amorphous calcium phosphate (ACP), amorphous calcium phosphate fluoride (ACPF), amorphous calcium carbonate phosphate (ACCP), amorphous calcium carbonate phosphate fluoride (ACCPF), and amorphous calcium fluoride (ACF) for use in remineralizing and fluoridating teeth. These amorphous compounds or solutions which form the amorphous compounds or calcium phosphate jelly which forms the amorphous compounds, when applied either onto or into dental tissue to prevent and/or repair dental weaknesses such as dental caries, exposed roots and dentin sensitivity. The compounds have the highest solubilities, fastest formation rates and fastest conversion rates (to apatite) among all the calcium phosphates under physiological conditions. Moreover, in the presence to fluoride the amorphous compound convert rapidly to fluoride containing apatite.

Abstract: A method for converting starting material to olefins comprising contacting the starting material with a small pore non-zeolitic molecular sieve catalyst under effective conditions to produce olefins, wherein the non-zeolitic molecular sieve has been prepared in-situ or modified after synthesis by incorporation using an alkaline earth metal compound, wherein the alkaline earth metal ion is selected from the group consisting of strontium, calcium, barium, and mixtures thereof.

Abstract: Bone graft substitute compositions are provided for promoting new bone growth and arthrodesis. The compositions include a carrier for controlled delivery of osteoinductive factors. In one embodiment, the carriers include a biphasic calcium phosphate ceramic having between about 2-40% hydroxyapatite and about 98-60% tricalcium phosphate by volume, and a calcium/phosphorous ratio of between about 1.50 to about 1.60. The invention also includes osteoinductive compositions including the carriers and an effective amount of a bone morphogenetic protein dispersed within the ceramic. The composition has a weight ratio of protein to ceramic of no more than about 1:200. In a specific embodiment, the weight ratio of protein to ceramic is between about 1:200 and about 1:2000.

Abstract: Microporous crystalline metallophosphate composition having an essential framework structure whose chemical composition in the as synthesised form expressed in terms of mole rations of oxides is: mR(M.sub.x Al.sub.y P.sub.z)O.sub.2 where M is silicon, x+y+z=1, m may have a value from 0.02 to 0.3, R is at least one templating agent, x, y and z represent the mole fractions of silicon, aluminium and phosphorous presentin the product, and where x may have a value from 0 to 0.5, y may have a value from 0.25 to 0.5 and z may have a value from 0.25 to 0.5, and where one reactive form of fluoride may be present in an effective amount to form the product, and having a characteristic X-ray powder diffraction pattern containing at least the d-spacings as set forth in Table 1.

Abstract: This invention involves new compositions and methods of use and delivery of amorphous calcium compounds such as: amorphous calcium phosphate (ACP), amorphous calcium phosphate fluoride (ACPF), amorphous calcium carbonate phosphate (ACCP), amorphous calcium carbonate phosphate fluoride (ACCPF), and amorphous calcium fluoride (ACF) for use in remineralizing and fluoridating teeth. These amorphous compounds or solutions which form the amorphous compounds or calcium phosphate jelly which forms the amorphous compounds, when applied either onto or into dental tissue to prevent and/or repair dental weaknesses such as dental caries, exposed roots and dentin sensitivity. The compounds have the highest solubilities, fastest formation rates and fastest conversion rates (to apatite) among all the calcium phosphates under physiological conditions. Moreover, in the presence to fluoride the amorphous compound convert rapidly to fluoride containing apatite.

Abstract: Solid mesoporous crystalline composition of a pyrophosphate-phosphate of a tetravalent metal, with a high surface area and narrow distribution of the mesopores, having formula (I):M(P.sub.2 O.sub.7).sub.1-z (HPO.sub.4).sub.2z (I)wherein: M is a tetravalent metal and z varies from 0.05 to 0.25.The process for its production is described together with its uses.

Abstract: Applicants have developed a continuous process for synthesizing various molecular sieves. The process enables one to control both the particle size and particle size distribution. Any of the molecular sieves represented by the empirical formula on an anhydrous basis: rR.sub.2 O:(Si.sub.x Al.sub.y P.sub.z)O.sub.2, where R is at least one templating agent, "r" "x" "y" and "z" are the mole fractions of R, Si, Al and P respectively, can be prepared using this process. The process involves continuously adding reactive sources of the desired components along with a structure directing agent into a continuous crystallization reactor. Either interstage backmixing is introduced or the number of stages is adjusted in order to control particle size. Finally, one way to control particle size distribution is to split the product stream into at least two streams and flowing each stream to a wet miller operated at different severity and then reblending to obtain at least a bimodal distribution.

Abstract: The present invention is a large-pore aluminophosphate or substituted aluminophosphate comprising a compositionaR:(M.sub.x Al.sub.y P.sub.z)O.sub.2wherein R represents an organic templating agent, and a=0 to 0.4, X=0 to 0.4, y=0.35 to 0.5, and Z=0.25 to 0.5 and characterized by the diffraction pattern of Table 1 and M may be Si, Ga, Ge, Co, Ni, Zn, Fe, V, Ti and mixtures thereof.

Abstract: Methods of making substantially phase-pure and thermally stable crystalline alumina compositions stabilized with an oxide of silicon, germanium, phosphorus, arsenic or a mixture thereof. Also provided are crystalline alumina compositions and catalyst supports made using these methods.

Abstract: A flowable, paste-like composition capable of setting in a clinically relevant period of time into an antimicrobial agent loaded apatitic product having sufficient compressive strength to serve as a cancellous bone structural material is provided. The subject compositions are prepared by combining dry ingredients with a physiologically acceptable lubricant and an antimicrobial agent, where the dry ingredients comprise at least two different calcium phosphates. The subject compositions find use in a variety of different applications, including orthopaedic, dental and cranio-maxillofacial applications.

Abstract: Two component, storage stable apatitic cement compositions, as well as methods for their production, are provided. The dry component of subject apatitic cements comprises basic calcium source particles at least partially coated with a partially neutralized acidic calciumim phosphate. The dry component of subject compositions is prepared by combining basic calcium source particles with dissolved acidic phosphate in at least a partially aqueous medium, whereby the basic calcium source particles become partially coated with a partially neutralized acidic calcium phosphate. The reaction is terminated prior to completion of the reaction between the acidic phosphate and the basic calcium source by removing the available water from the reaction mixture. In a first mode, the subject cement may be produced by mechanically mixing an acidic phosphate source with basic calcium source particles in the presence of an aqueous solvent and stopping the reaction between the acid and base prior to completion.

Abstract: Carbonated hydroxyapatite compositions and their preparation are described. The compositions are biologically resorbable and are prepared as flowable masses which can be administered by syringe to set in situ to serve as a support structure, filler, prosthesis or the like. Optionally the compositions may include proteins or serve as a depot for compositions of phrarmacological interest.

Abstract: A process for producing an alkali metal polyphosphate, comprising heating a solution comprising a solvent, alkali metal ions, phosphate ions, and 3 to 50% by weight of organic matter, wherein the solution contains, in total, 5 to 65% by weight of the alkali metal ions and the phosphate ions, and the ratio M/P is 1.0 to 3.0, wherein M is the number of moles of alkali metal ions in the solution and P is the number of moles of orthophosphate ions in the solution, at a temperature of 800.degree. to 1200.degree. C. in the presence of excess air, optionally after the solution is at least partially dried to solid, to produce the alkali metal polyphosphate.

Abstract: Carbonated hydroxyapatite compositions and their preparation are described. The compositions are biologically resorbable and are prepared as flowable masses which can be administered by syringe to set in situ to serve as a support structure, filler, prosthesis or the like.

Abstract: Uniformly sized and shaped particles of metal salts are provided comprised of one or more metal cations in combination with one or more simple oxoacid anions and a general method for the controlled precipitation of said metal salts from aqueous solutions. The methods proceed via the in situ homogeneous production of simple or complex oxoacid anions in which one or more of the nonmetallic elements e.g. Group 5B and 6B (chalcogenides), and 7B (halides) comprising the first oxoacid anion undergo oxidation to generate the precipitant anionic species along with concurrent reduction of the nonmetallic element of a second, dissimilar oxoacid anion. The oxoacid anions are initially present in solution with one or more metal cations known to form insoluble salts with the precipitant anion.

Abstract: A catalyst for converting methanol to light olefins along with the process itself are disclosed and claimed. The catalyst is a metalloaluminophosphate molecular sieve having the empirical formula (EL.sub.x Al.sub.y P.sub.z)O.sub.2 where EL is a metal such as silicon or magnesium and x, y and z are the mole fractions of EL, Al and P respectively. The molecular sieve has a crystal morphology in which the average smallest crystal dimension is at least 0.1 microns. Use of this catalyst gives a product with a larger amount of ethylene versus propylene.

Abstract: Carbonated hydroxyapatite compositions and their preparation are described. The compositions are biologically resorbable and are prepared as flowable masses which can be administered by syringe to set in situ to serve as a support structure, filler, prosthesis or the like. Optionally the compositions may include proteins or serve as a depot for compositions of phrarmacological interest.

Abstract: Methods for the production of nickel or ammonium hypophosphite are disclosed, including combining sodium hypophosphite with nickel or ammonium sulfate to produce sodium sulfate and nickel or ammonium hypophosphite, and lowering the temperature of the solution containing the sodium sulfate to crystallize out the sodium sulfate.

Abstract: Support for catalysts, containing at least two constituents chosen from silica, alumina and aluminium phosphate, having a specific surface of 100 to 800 m.sup.2 /g, a crystallization temperature greater than or equal to 700.degree. C. and a pore volume of 1.5 to 4 cm.sup.3 /g, the specific surface (SS) and the pore volume (PV) corresponding to the relationship:SS<(PV.times.564-358).Process for the manufacture of such a support, according to which an alcohol, water, a silicon alkoxide and an acid are mixed under conditions such that gelling or precipitation of silica is prevented, an acidic solution of an aluminium compound and/or a solution of a source of phosphate ions are added thereto, a gelling agent is added thereto, a gel is recovered which is washed with water and then by means of an organic liquid, the gel is then dried until a powder is obtained, and the powder is calcined. Polymerization of olefins in the presence of a catalyst containing chromium on a support as described above.

Abstract: Two component, storage stable apatitic cement compositions, as well as methods for their production, are provided. The dry component of subject apatitic cements comprises basic calcium source particles at least partially coated with a partially neutralized acidic calcium phosphate. The dry component of subject compositions is prepared by combining basic calcium source particles with dissolved acidic phosphate in at least a partially aqueous medium, whereby the basic calcium source particles become partially coated with a partially neutralized acidic calcium phosphate. The reaction is terminated prior to completion of the reaction between the acidic phosphate and the basic calcium source by removing the available water from the reaction mixture. In a first mode, the subject cement may be produced by mechanically mixing an acidic phosphate source with basic calcium source particles in the presence of an aqueous solvent and stopping the reaction between the acid and base prior to completion.

Abstract: A method of making an inorganic salt-hydrogen peroxide complex includes the following steps: (a) mixing the inorganic salt with sufficient water for a time sufficient to form a soft paste, (b) mixing the paste with an aqueous hydrogen peroxide solution to form a hydrogen peroxide-containing paste, and (c) drying the hydrogen peroxide-containing paste. A hydrate method of making Na.sub.4 P.sub.2 O.sub.7.3H.sub.2 O.sub.2 includes the steps of: mixing sodium pyrophosphate decahydrate solid with an aqueous solution of hydrogen peroxide having a concentration of less than 30%, and drying the mixture. Compositions of matter include K.sub.2 HPO.sub.4.3H.sub.2 O.sub.2, KH.sub.2 PO.sub.4.H.sub.2 O.sub.2 Ca.sub.2 P.sub.2 O.sub.7.nH.sub.2 O.sub.2, Ca.sub.2 P.sub.2 O.sub.4.nH.sub.2 O.sub.2, Na.sub.2 SO.sub.4.nH.sub.2 O.sub.2, K.sub.2 SO.sub.4.nH.sub.2 O.sub.2, Na.sub.2 SiO.sub.3.nH.sub.2 O.sub.2 and Na.sub.2 SiO.sub.7.nH.sub.2 O.sub.2.

Abstract: Calcium phosphate cements are provided. The subject cements comprise amorphous calcium phosphate, at least one additional calcium source, usually an additional calcium phosphate, and a liquid component, such as a physiologically acceptable lubricant. Upon combination of the cement components, a flowable composition capable of setting in vivo into a solid calcium phosphate mineral product, such as hydroxyapatite, is produced. The subject cement compositions find use in a variety of applications, including the treatment of injured or compromised hard tissue.